Webinar | Proton Therapy| May 31, 2016

Webinar: Expanding Oncology Services With Proton Therapy

This webinar is sponsored by IBA

proton therapy, IBA, proteusPlus

This one-hour webinar explains how a community hospital, Willis-Knighton Health Systems, established a proton therapy center in less than 13 months. The Willis-Knighton Proton Therapy Center, adjacent to the hospital's existing cancer center, allows for economies of scale and continuity of care, and contains the world's first compact pencil-beam scanning proton therapy system. Experts who set up the Willis-Knighton Proton Therapy Center explains the clinical benefits of proton therapy and how it can potentially expand oncology services.

This webinar took place Thursday, June 30. 

Access the archived version of this webinar



Lane Rosen, M.D., medical director of radiation oncology, Willis-Knighton Health System, Shreveport, La., is board certified (American Board Radiology). He has special interests in female malignancies, TomoTherapy, treatment of previously irradiated tumors, high dose rate (HDR) brachytherapy, and intensity modulated proton therapy (IMPT). A fifth-generation Shreveport native, Rosen is a member of the Shreveport Medical Society, Louisiana State Medical Society, the American Medical Association, the Association of Residents in Radiation Oncology (residency), the American Society of Therapeutic Radiology and Oncology, the American College of Radiation Oncology, and the Society of Neuro-Oncology.


Greg Sonnenfeld, director, Willis-Knighton Cancer Center – Willis-Knighton Health System, has been in healthcare for more than 15 years. He was instrumental in the development, construction and operation of the Willis-Knighton Proton Therapy Center and has led the oncology team to tremendous growth in the past seven years. Sonnenfeld has spoken on proton therapy at numerous symposiums and is an expert on proton therapy in the community hospital setting.



Mary Elizabeth (Beth) Klein, president, IBA Proton Therapy North America, is a tenured healthcare executive responsible for leading IBA’s Proton Therapy business in North America. Prior to joining IBA in 2009, she spent 27 years at GE Healthcare in sales, marketing and product development in CT, MR and ultrasound. She led GE’s unprecedented growth in nuclear imaging and PET as the global general manager for that business, and completed her tenure at GE Healthcare as the president and CEO of the Americas. She was also the commercial executive at TomoTherapy responsible for its orders ramp in 2005-2007 and played a key role in its public offering. Beth is passionately committed to growing proton therapy as a important tool in delivering more effective cancer treatments for patients.



About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer to the medical communities and their patients. The company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single-room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,200 people worldwide, IBA is listed on the Pan-European stock exchange EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) More information can be found at: www.iba-worldwide.com. 

About Willis-Knighton Medical Center

Founded in 1924 as Tri-State Sanitarium in Shreveport, La., Willis-Knighton Medical Center was renamed in 1950 to honor the two physicians who purchased the hospital and transitioned it to a not-for-profit healthcare organization. Today, it encompasses multiple facilities, including four hospitals, a full range of support services, and a retirement community. It spans the entire continuum of care for residents in northwest Louisiana and the Ark-La-Tex area. Willis-Knighton was the first private hospital in the state to team with a public, academic medical center, Louisiana Health Sciences Center in Shreveport, on collaborative ventures. Great strides in cancer care have been made at the Willis-Knighton Cancer Center, one of the first in the world to introduce TomoTherapy image-guided radiation therapy. As a locally owned, locally operated healthcare organization, Willis-Knighton supports continuing efforts to enhance Shreveport’s position as a hub of healthcare excellence.


Access the archived version of this webinar

Related Content

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Overlay Init